NEJM publishes results from phase 2 study of vaccines reducing TB infections
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AbbVie: NEJM publishes 24-week results from Phase 3 RINVOQ study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Acceleron says NEJM publishes results of Pulsar Phase 2 trial of sotatercept
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Teva publishes Phase 3b FOCUS study results
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
VBI Vaccines Announces Second Quarter 2019 Financial Results and Provides Corporate Update
Positive top-line data from PROTECT Phase 3 for Sci-B-Vac®, trivalent hepatitis B vaccine, announced June 2019 – top-line data from second Phase 3 study, CONSTANT, expected aroun.....»»
Akcea announces NEJM publishes Waylivra study results
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Intec Pharma publishes results from Phase 2 clinical study of AP-CD/LD
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
BioMarin publication of results from Phase 2 study for vosoritide in NEJM
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
VBI Vaccines announces "positive" final Phase 1 study results for VBI-1501
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Genentech Phase III HAVEN 3 study results published in NEJM
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
VBI Vaccines Provides Corporate Update, Outlook for 2019, and Year-End 2018 Financial Results
Top-line data from Hepatitis B (Sci-B-Vac®) Phase 3 PROTECT trial expected mid-year 2019 Encouraging early immunogenicity data from GBM Phase 1/2a supports advancing into Part B of the study License and Collaboration with Brii Biosciences, to develop.....»»
Biovitrum and Apellis report results from phase 3 PRINCE study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Apellis, Swedish Orphan Biovitrum report results from Phase 3 Prince study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Genentech announces interim results from Phase III IMpower010 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Baudax Bio announces publication of results from Phase IIIb study of ANJESO
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Biogen"s Retinal Disease Gene Therapy Flunks Mid-Stage Study
Biogen Inc (NASDAQ: BIIB) has announced topline results from the Phase 2/3 XIRIUS study evaluating cotoretigene toliparvovec (BIIB112), a gene therapy being investigated as a one-time therapy for patients w.....»»
ContraFect Reports First Quarter 2021 Financial Results and Provides Business Update
Interim futility analysis from the Phase 3 DISRUPT study of exebacase evaluating treatment superiority is anticipated in H2 2021 BARDA contract award provides up to $86.8 million for exebacase development Strong fi.....»»
Protagonist to update on results from Phase 2 Study of rusfertide at EHA 2021
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
VBI Vaccines publishes Protect results of company"s-antigen Hep B vaccine
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Psyched: Groundbreaking Phase 3 Results On MDMA, Small Pharma, Wesana Go Public, Gilgamesh Raises $27M
Last week, the psychedelics space was moved by results from the world’s first Phase 3 clinical study of a scheduled psychedelic compound. read more.....»»
Diffusion Pharmaceuticals reports results from Phase 1b study of TSC
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»